The trademark Atecan was filed by MEDICE Arzneimittel GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on May 12, 2020, and received one opposition filed on August 12, 2020 by Cheplapharm Arzneimittel GmbH on Likelihood of confusion. the opponent was represented by HABERMANN INTELLECTUAL PROPERTY PARTNERSCHAFT VON PATENTANWÄLTEN MBB and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 12, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2021.